Added to YB: 2023-12-20
Pitch date: 2023-12-20
INTS:US [bullish]
Intensity Therapeutics, Inc.
-97.2%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States.
Market Cap
$11.1M
Pitch Price
$151.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.08
P/E
-0.70
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Intensity Therapeutics, Inc. INTS:US
A summary for this pitch has not been created yet.
Read full article (0 min)